From Drugs of Abuse to Parkinsonism. The MPTP Mouse Model of Parkinson's Disease
Overview
Authors
Affiliations
Osmanovic Barilar J, Knezovic A, Babic Perhoc A, Homolak J, Riederer P, Salkovic-Petrisic M J Neural Transm (Vienna). 2020; 127(2):231-250.
PMID: 32030485 PMC: 7035309. DOI: 10.1007/s00702-020-02152-8.
Datta I, Mekha S, Kaushal A, Ganapathy K, Razdan R Naunyn Schmiedebergs Arch Pharmacol. 2019; 393(2):147-165.
PMID: 31468077 DOI: 10.1007/s00210-019-01715-1.
NMR Metabolomics Analysis of Parkinson's Disease.
Lei S, Powers R Curr Metabolomics. 2015; 1(3):191-209.
PMID: 26078917 PMC: 4465192. DOI: 10.2174/2213235X113019990004.
Duty S, Jenner P Br J Pharmacol. 2011; 164(4):1357-91.
PMID: 21486284 PMC: 3229766. DOI: 10.1111/j.1476-5381.2011.01426.x.
Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.
Antzoulatos E, Jakowec M, Petzinger G, Wood R Pharmacol Biochem Behav. 2010; 95(4):466-72.
PMID: 20347863 PMC: 2866026. DOI: 10.1016/j.pbb.2010.03.009.